Abstract
Twelve patients with recurrent polyserositis (RP, familial Mediterranean fever) on colchicine prophylaxis (1.0–2.0 mg daily) for three years or more were evaluated for the presence of gastrointestinal effects possibly attributable to the drug. Two patients had bulky stools, two others had transient diarrhea, and one had heartburn. Serum vitamin B12, calcium, and carotene levels were normal in all cases, andd-xylose absorption was normal in 11 of the 12. Three patients had mild steatorrhea (7.5, 7.9, and 9.9 g daily). Jejunal biopsies from these and a fourth patient with bulky stools but normal fecal fat excretion showed no abnormal histological changes. However, (Na+K)-ATPase activity was significantly decreased in all four cases. Colchicine had to be discontinued in only one of the 12 cases. It is concluded that mild steatorrhea and enzyme inhibition may occur in patients on long-term colchicine prophylaxis and that careful periodic observations for this and other adverse effects is imperative in such patients.
Similar content being viewed by others
References
Shanbrom E, Raporport L: Gastrointestinal complications of colchicine therapy in gout. Ann Intern Med 48:655–660, 1958
Race TF, Paes IC, Faloon WW: Intestinal malabsorption by oral colchicine. Clin Res 14:480, 1966
Gaultier M, Kaufer A, Bismuth C: Donnees actuelles sur l'intoxication aigue par la colchicine. Ann Med Interne 120:605–618, 1969
Race TF, Paes IC, Faloon WW: Intestinal malabsorption induced by oral colchicine. Comparison with neomycin and carthartic agents. Am J Med Sci 259:32–41, 1970
Stemmerman GN, Hayashi T: Colchicine intoxication: A reappraisal of its pathology based on a study of three fatal cases. Hum Pathol 2:321–328, 1971
Heany D, Derghazarian CB, Pineo GF, Ali MAM: Massive colchicine overdose: A report on the toxicity. Am J Med Sci 271:233–238, 1976
Clark PA, Harland WA: Experimental malabsorption with jejunal atrophy induced by colchicine. Br J Exp Pathol 44:520–523, 1963
Luketic GC, Shapiro M: Effect of colchicine on xylose absorption in dogs. Clin Res 1:31, 1964
Luketic GC, Myren J, Sachs G, Hirschowitz BI: Effect of therapeutic doses of colchicine on oxidative enzymes in the intestine. Nature 202:608–609, 1964
Levin RJ: Effect of colchicine on intestinal function in the rat. Gut 7:250–257, 1966
Myren J, Luketic GC, Ceballos R, Sachs G, Hirschowitz BI: Effects of colchicine on intestinal mucosal dehyrogenases. 1. Histochemical observations. Am J Dig Dis 11:394–403, 1966
Fredricsson B, Wirsén C:In vivo effect of colchicine on alkaline phosphates of rat intestinal epithelium. Exp Cell Res 10:749–751, 1957
Luketic GC, Sachs G, Myren J, Tsuji T, Hirschowitz BI: Effects of colchicine on intestinal mucosal dehydrogenases. II. Biochemical observations. Am J Dig Dis 11:404–409, 1966
Herbst JJ, Hurwitz R, Sunshine P, Kretchmer N: Effect of colchicine on intestinal disaccharidases: Correlation with biochemical aspects of cellular renewal. J Clin Invest 49:530–536, 1970
Cohen MI, McNamara H: The effect of colchicine on guineapig intestinal enzyme activity. Am J Dig Dis 15:247–250, 1970
Dinarello CA, Wolff SM, Goldfinger SE, Dale DC, Alling DW: Colchicine therapy for familial Mediterranean fever. A double bind trial. N Engl J Med 291:934–937, 1974
Zemer D, Revach M, Pras M, Modan B, Schor S, Sohar E, Gafni J: A controlled trial of colchicine in preventing attacks of familial Mediterranean fever. N Engl J Med 291:932–934, 1974
Levy M, Eliakim M: Long-term colchicine prophylaxis in familial Mediterranean fever. Br Med J 2:808, 1977
Tripp JH, Manning JA, Muller DRP, Walker-Smith BA, Harris JT: Mucosal adenylate cyclase and sodium-potassium stimulated adenosine triphosphate in jejunal biopsies of adults and children with coeliac disease.In Perspectives in Coeliac Disease. B McNichol, CF McCarthy, PF Fottrell (eds). Lancaster, U.K., MTP Press, 1978, pp 461–470
Faloon WW, Webb DI, Race TF: Cholesterol lowering effect of colchicine. Ann Intern Med 16:1058, 1967
Webb DI, Chodos RB, Mahar CQ, Faloon WW: Mechanism of vitamin B12 malabsorption in patients receiving colchicine. N Engl J Med 279:845–850, 1968
Faloon WW, Rublis A, Race TF, Webb DI: Colchicine and cholesterol metabolism. Am J Clin Nutr 22:671–672, 1969
Rublis A, Rubert M, Faloon WW: Cholesterol lowering, fecal bile acid, and sterol changes during neomycin and colchicine. Am J Clin Nutr 28:1251–1259, 1975
Yu TF, Gutman AB: Efficacy of colchicine prophylaxis in gout. Prevention of recurrent gouty arthritis over a mean period of five years in 208 gouty subjects. Ann Intern Med 55:179–192, 1961
Hawkins CF, Ellis HA, Rawson A: Malignant gout with tophaceous small intestine and megaloblastic anemia. Ann Rheum Dis 24:224–233, 1965
Rachmilewitz D, Fogel R, Karmeli F: Effect of colchicine and vinblastine on rat intestinal water transport Na-K-ATPase activity. Gut 19:759–764, 1978
Rachmilewitz D, Karmeli F, Okon E: Effect of bisacodyl on cAMP and prostaglandin E2 contents (Na-K)ATPase, adenyl cyclase and phosphodiesterase activities of rat intestine. Dig Dis Sci 25:602–608, 1980
Sharon P, Rachmilewitz D, Karmeli F: Effect of pentagastrin on rat jejunal fluid transport, prostaglandin E2 content, Na-K-ATPase and adenyl cyclase activities. Prostaglandins 21:81–87, 1981
Charney AN, Donowitz M: Functional significance of intestinal Na-K-ATPase:In vivo ouabain inhibition. Am J Physiol 234:629–636, 1978
Venho VKM, Koivuniemi A: Effect of colchicine on drug absorption from the rat small intestinein situ andin vitro. Acta Pharmacol Toxicol 43:251–259, 1978
Stopa EG, O'Brien R, Katz M: Effect of colchicine on guinea pig intrinsic factor-vitamin B12 receptor. Gastroenterology 76:309–314, 1979
Zylber-Katz E, Ehrenfeld M, Levy M, Eliakim M: Plasma colchicine concentrations in patients with recurrent polyserositis (familial Mediterranean fever) on long-term prophylaxis. Arthritis Rheum (in press)
Gilat T, Revach M, Sohor E: Depositions of amyloid in the gastrointestinal tract. Gut 10:98–104, 1969
Yoran C, Weber H, Gilat T: Studies on gastrointestinal functions in amyloidosis of familial Mediterranean fever. Scand J Gastroenterol 4:275–279, 1969
Cohen MM, Levy M, Eliakim M: A cytogenetic evaluation of long term colchicine therapy in the treatment of familial Mediterranean fever. Am J Med Sci 274:147–152, 1977
Levy M, Yaffe C: Testicular function in patients with familial Mediterranean fever on long-term colchicine treatment. Fertil Steril 29:667–668, 1978
Eliakim M, Levy M, Ehrenfeld M: Recurrent Polyserositis (Familial Mediterranean Fever, Periodic Disease). Amsterdam, Elsevier/North-Holland Biomedical Press, 1981
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ehrenfeld, M., Levy, M., Sharon, P. et al. Gastrointestinal effects of long-term colchicine therapy in patients with recurrent polyserositis (familial Mediterranean fever). Digest Dis Sci 27, 723–727 (1982). https://doi.org/10.1007/BF01393768
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01393768